Cargando…

The cyclin dependent kinase inhibitor Roscovitine prevents diet-induced metabolic disruption in obese mice

Most strategies to treat obesity-related disorders have involved prevention of diet-induced weight gain in lean mice. Treatment of obese individuals will require therapies that reverse the detrimental effects of excess body weight. Cyclin-dependent kinases have been shown to contribute to obesity an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rabhi, Nabil, Desevin, Kathleen, Cortez, Briana Noel, Hekman, Ryan, Lin, Jean Z., Emili, Andrew, Farmer, Stephen R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514475/ https://www.ncbi.nlm.nih.gov/pubmed/34645915 http://dx.doi.org/10.1038/s41598-021-99871-z

Ejemplares similares

Shifts of Immune Cell Populations Differ in Response to Different Effectors of Beige Remodeling of Adipose Tissue
por: Rabhi, Nabil, et al.
Publicado: (2020)

Several Human Cyclin-Dependent Kinase Inhibitors, Structurally Related to Roscovitine, As New Anti-Malarial Agents
por: Houzé, Sandrine, et al.
Publicado: (2014)

Human embryonic stem cells display a pronounced sensitivity to the cyclin dependent kinase inhibitor Roscovitine
por: Videla-Richardson, Guillermo A., et al.
Publicado: (2019)

Obesity-induced senescent macrophages activate a fibrotic transcriptional program in adipocyte progenitors
por: Rabhi, Nabil, et al.
Publicado: (2022)

Cyclin-dependent kinase inhibitor r-roscovitine reduces lipoteichoic acid lung inflammation and improves the resolution of antibiotic-treated Streptococcus pneumoniae pneumonia
por: Hoogendijk, AJ, et al.
Publicado: (2009)

Roscovitine, a Cyclin-Dependent Kinase-5 Inhibitor, Decreases Phosphorylated Tau Formation and Death of Retinal Ganglion Cells of Rats after Optic Nerve Crush
por: Hirokawa, Takahisa, et al.
Publicado: (2021)

Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication
por: Huang, Qi, et al.
Publicado: (2020)

A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days
por: Benson, C, et al.
Publicado: (2007)

Antifibrotic Effects of Roscovitine in Normal and Scleroderma Fibroblasts
por: Steinman, Richard A., et al.
Publicado: (2012)

The Cdk5 inhibitor Roscovitine increases LTP induction in corticostriatal synapses
por: Miranda-Barrientos, Jorge, et al.
Publicado: (2014)

Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity
por: Iqbal, Niloy Jafar, et al.
Publicado: (2018)

Selective antitumor activity of roscovitine in head and neck cancer
por: Gary, Cyril, et al.
Publicado: (2016)

R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair
por: Federico, Mario, et al.
Publicado: (2010)

The molecular determinants of R-roscovitine block of hERG channels
por: Cernuda, Bryan, et al.
Publicado: (2019)

Roscovitine ameliorates endotoxin-induced uveitis through neutrophil apoptosis
por: Jiang, Zhao-Xin, et al.
Publicado: (2016)

Enhancement of Peripheral Nerve Regrowth by the Purine Nucleoside Analog and Cell Cycle Inhibitor, Roscovitine
por: Law, Vincent, et al.
Publicado: (2016)

Unraveling the complexity of thermogenic remodeling of white fat reveals potential antiobesity therapies
por: Rabhi, Nabil, et al.
Publicado: (2021)

The Emerging Role of Cyclin-Dependent Kinase Inhibitors in Treating Diet-Induced Obesity: New Opportunities for Breast and Ovarian Cancers?
por: Benot-Dominguez, Reyes, et al.
Publicado: (2022)

Roscovitine Suppresses CD4+ T Cells and T Cell-Mediated Experimental Uveitis
por: Zhang, Zili, et al.
Publicado: (2013)

Roscovitine protects murine Leydig cells from lipopolysaccharide-induced inflammation
por: Xie, Tiancheng, et al.
Publicado: (2017)

Effect of roscovitine on developmental competence of small follicle-derived buffalo oocytes
por: Pandey, Sriti, et al.
Publicado: (2018)

Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
por: Nair, Binoj C, et al.
Publicado: (2011)

Exploring the Relationship between the Inhibition Selectivity and the Apoptosis of Roscovitine-Treated Cancer Cells
por: Cui, Chunying, et al.
Publicado: (2013)

Correction: Roscovitine Suppresses CD4+ T Cells and T Cell-Mediated Experimental Uveitis
por: Zhang, Zili, et al.
Publicado: (2013)

R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy
por: Tejero, Rocio, et al.
Publicado: (2020)

Cyclin kinase inhibitors and interferons in lupus
por: Theofilopoulos, A
Publicado: (2003)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

The Adipocyte Acquires a Fibroblast-Like Transcriptional Signature in Response to a High Fat Diet
por: Jones, Jessica E. C., et al.
Publicado: (2020)

Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents
por: Montanaro, Gabriele, et al.
Publicado: (2013)

Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016)

CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD
por: Bukanov, Nikolay O., et al.
Publicado: (2012)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

Cyclin-dependent kinase inhibitors in malignant hematopoiesis
por: Schirripa, Alessia, et al.
Publicado: (2022)

Cyclin-dependent kinase 1 disruption inhibits angiogenesis by inducing cell cycle arrest and apoptosis
por: Gao, Xin, et al.
Publicado: (2019)

Interference with platelet-derived growth factor-induced signalling in vascular smooth muscle cells by roscovitine
por: Sroka, Irene, et al.
Publicado: (2008)

Phenol red in the culture medium strongly affects the susceptibility of human MCF-7 cells to roscovitine
por: Węsierska-Gądek, Józefa, et al.
Publicado: (2007)

Defining the mechanisms underlying cyclin dependent kinase control of HIF-1α
por: Warfel, Noel A.
Publicado: (2022)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
por: Giannone, Gaia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cnjueqov23pec8r2gi2achis5a